Gsk Share Discussion Threads

[alphorn] 06/8/2018 15:31

We shall also have to wait and see for the post Brexit tax situation.

[alphorn] 06/8/2018 15:29

Bit OTT there TM.

A large part of R&D activities are in the UK (work permits?); Clinical work (Euro Centre moving out of London); Actives produced overseas (Imports); Exports of product(permits); IP (nobody knows) just to name a few.

'of any kind' is not a phrase that I would have used.

[tradermichael] 06/8/2018 15:22

GSK has a significant global presence with commercial operations in more than 150 countries, a network of 86 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China. Simply because it is a UK company does not mean that its operations are vulnerable to Brexit of any kind.

[rsharman] 06/8/2018 14:35

Agree with all Garycook says. Buywell - Why would GSK be hard hit with other Pharmers. Surely no Brexit deal would hit sterling and help GSK. Any clarification welcome. Thanks

[garycook] 06/8/2018 14:10

Improving outlook

With the GlaxoSmithKline share price having risen by 19% since the start of the year, it continues to beat the FTSE 100. More outperformance could be ahead, since the business seems to be heading in the right direction when it comes to its strategy. It has a diverse business model and has resisted calls from some investors to split into different entities. In its current state, it offers a mix of growth potential from its pipeline and consumer brands, as well as defensive characteristics due in part to its diverse range of operations.

With GlaxoSmithKline having a dividend yield of around 5.2%, it continues to offer a wide margin of safety. Given that dividends have not risen in recent years, its cover is now at around 1.4. This suggests that dividend growth could restart over the medium term, and this may lead to an improving investment outlook.

Although the FTSE 100’s prospects appear to be sound, buying defensive stocks could be a shrewd move. The next bear market may not be too far away, and companies such as GlaxoSmithKline may perform better in more difficult trading conditions than the majority of their index peers.

[atlantic57] 06/8/2018 13:50

Agreed Jim Rogers recent record not good.
However I don’t know 0f any reliable forcaster

So many publications bombard you covering every eventuality and then tell you
That they predicted what was coming.

[dr biotech] 06/8/2018 12:51

Jim Rodgers did well betting against the BoE but his record since then hasn't been great. He's been in the telegraph a few times and all of his calls have been badly wrong. One swallow doth not make a summer etc.

I've sold half my holding here today. Thats about 13% up since I bought them (inc dividends). I struggle to see where the growth is going to come from, and I don't see the markets performing generally over the next few months with the US/China & Brexit issues muddying the waters somewhat. Hopefully will be proved wrong though.

[fangorn2] 06/8/2018 12:45

@Atlantic,

indeed the funny money(AKA QE) has propped up western economies. growth has been anaemic despite the trillions thrown at it. That , in itself, should tell you there are real serious problems.

QE being withdrawn, interest rates rising.
Double whammy.
Wont end well for so many over leveraged people...and for many others used to living beyond their means, the fate will be similar.

Concerning times for such heralds in a "Socialist Govt"
The appeal of "freebies" is most enticing.

No such thing of course as someone,somewhere, is paying.

Very worrying times.

[buywell3] 06/8/2018 12:36

A Hard Brexit is going to hurt BIG Pharmas more than most


........... Trump told May to sue the EU ...............


It will soon become apparent that article 50 will make the UK electorate see that Trump gave May wise council

However as May would not have been employed as Mrs T's tea lady , let alone No 10 sweeper up , she has not the nous to understand that what Trump was passing on was expert legal advice from some of the top USA lawyers , experts at what America does best

Sue the @rse of anything they can.

In the case of the EU, they deserve to be taken to the cleaners , where May works weekends I believe.

[tim 3] 06/8/2018 11:55

Nice rice to recent resistance.


On Jim Rogers he has been predicting a crash for as long as I can remember!

He also said things would get much worse in the US after 2008 and the Dow has doubled since then!

In my book that makes him spectacularly wrong even if it does crash at some point in the future.

[badtime] 06/8/2018 11:35

Ok as it's predicting season ..I'm going for a wet Autumn/Winter ..we had a relatively cold one ..hot summer ..

[quepassa] 06/8/2018 11:27

Graph showing great strength and stellar recovery since February 1250p lows.

UBS put out a repeat BUY Recommendation on Friday with their recently increased (30/7)
TARGET PRICE of 1700p.


Looking good.

More to come.

ALL IMO. DYOR.
QP

[atlantic57] 06/8/2018 11:07

Fangorn that is a good summary I have been expecting a crash for some time but the central bankers have managed to keep the show on the road.

I think Trump May fire the fed chief Jerome Powell before the end of the year.Trump has tweeted regularly that he wants a weak dollar so he is on a collision course with Powell who has clearly signalled his intention to raise interest rates.

[ny boy] 06/8/2018 10:55

Nice price action, divi hunters bought the recent dip ..I did.

Should eventually show some defensive qualities going fwd.

[fangorn2] 06/8/2018 10:53

@Alphorn,

Water,And precious metals imo.
Everything else negotiable.

:)

[alphorn] 06/8/2018 10:47

Fangorn - maybe; but then the question arises - which asset class to go for? (Within equities Big Pharma may escape somewhat?)

[fangorn2] 06/8/2018 10:42

@Atlantic,

Interest rate rises will be biting by may/June next year.
As well as that trade war currently simmering in background.

10yr UST's will hit 3.5%

Bond bubble finally going to burst. Massively overbought.

Going to be a very cold miserable winter as well.

[atlantic57] 06/8/2018 10:16

Fangorn if accurate that is priceless
Information.

How have you arrived at these dates.?
Jim Rogers favours 2019.

I will go into cash on 30 April 2019:))

[atlantic57] 05/8/2018 18:56

Alphorn agreed the point is that no investment is 100% safe.
Whether that is due to commercial risk or a market crash.

[alphorn] 05/8/2018 16:33

The fall from £22 had little to do with the financial crisis.

[atlantic57] 05/8/2018 14:33

Nothing is safe and initially everything falls whenever there is a financial crisis.
The emperor is naked but could stay naked for some time.

Gsk is not immune to a financial crisis.

Howvever it should recover once the dust settles from any fall.

[whatsup32] 05/8/2018 11:10

Yes I see your point Alphorn. £22 to £10 . I bought if memory serves me right about £14.50 then it went down to £11 ish. But I just held it collecting dividends and it gradually came back to a decent capital profit. In and out a few` times.

I find the company to be conservative in their approach to business , div 4 times a year, some protection against the fall in the pound a decent defensive stock . With operations through out the world , so if one nation has problems it’s ofset by growth in another country.

No company is entirely safe

[alphorn] 04/8/2018 21:16

You may have lost some sleep some years ago when the share price fell from its highs. Not always safe.

[whatsup32] 04/8/2018 18:15

Well said Atlantic57

You can’t go too wrong with GSK. With Brexit uncertainty it’s a must hold . Like the fact you get Dividends 4 times a year and it’s a good balance against the pound dropping in value.

I never lost sleep holding GSK